Article
Evaluation of Papanicolaou smears in pemphigus vulgaris patients before and after rituximab
2026-01-16
Abstract excerpt
<title>Abstract</title> <p> Background Pemphigus vulgaris (PV) is a potentially fatal autoimmune mucocutaneous blistering disease. Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that is increasingly being used and becoming the first-line therapy in the management of PV. Its impact on cervical cytology and human papillomavirus (HPV) infection risk in this population remains unclear. Objectives To p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bbc92540-a800-5fe4-89fc-19eba89bfef5
- DOI
- 10.21203/rs.3.rs-7912509/v1
